CN102260653A - 一种peg化重组猪-人尿酸氧化酶融合蛋白的制备及应用方法 - Google Patents
一种peg化重组猪-人尿酸氧化酶融合蛋白的制备及应用方法 Download PDFInfo
- Publication number
- CN102260653A CN102260653A CN201110181447A CN201110181447A CN102260653A CN 102260653 A CN102260653 A CN 102260653A CN 201110181447 A CN201110181447 A CN 201110181447A CN 201110181447 A CN201110181447 A CN 201110181447A CN 102260653 A CN102260653 A CN 102260653A
- Authority
- CN
- China
- Prior art keywords
- oxidase
- urico
- human
- pig
- peg
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Images
Landscapes
- Enzymes And Modification Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Description
Claims (12)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 201110181447 CN102260653B (zh) | 2011-06-30 | 2011-06-30 | 一种peg化重组猪-人尿酸氧化酶融合蛋白的制备及应用方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 201110181447 CN102260653B (zh) | 2011-06-30 | 2011-06-30 | 一种peg化重组猪-人尿酸氧化酶融合蛋白的制备及应用方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102260653A true CN102260653A (zh) | 2011-11-30 |
CN102260653B CN102260653B (zh) | 2013-04-03 |
Family
ID=45007494
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 201110181447 Active CN102260653B (zh) | 2011-06-30 | 2011-06-30 | 一种peg化重组猪-人尿酸氧化酶融合蛋白的制备及应用方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102260653B (zh) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2012109975A1 (zh) * | 2011-02-14 | 2012-08-23 | 重庆富进生物医药有限公司 | 聚乙二醇化犬源尿酸氧化酶类似物蛋白及其制备方法和用途 |
CN105412942A (zh) * | 2015-12-23 | 2016-03-23 | 沈阳三生制药有限责任公司 | 聚乙二醇化的重组产朊假丝酵母尿酸氧化酶冻干注射剂 |
CN108103079A (zh) * | 2017-06-20 | 2018-06-01 | 北京五加和分子医学研究所有限公司 | 一种高尿酸血症的基因治疗药物 |
CN111500550A (zh) * | 2020-04-02 | 2020-08-07 | 北京翼方生物科技有限责任公司 | 一种可降解人体血尿酸的过滤介质及其制备方法 |
CN113144174A (zh) * | 2020-01-22 | 2021-07-23 | 杭州远大生物制药有限公司 | 治疗高尿酸相关性疾病的药物 |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1322141A (zh) * | 1998-08-06 | 2001-11-14 | 山景药品公司 | 聚乙二醇或聚环氧乙烷-尿酸氧化酶结合物及其应用 |
WO2003011211A2 (en) * | 2001-08-02 | 2003-02-13 | Phoenix Pharmacologics, Inc. | Peg-modified uricase |
US7056713B1 (en) * | 1998-08-06 | 2006-06-06 | Duke University | Urate oxidase |
CN101198693A (zh) * | 2005-04-11 | 2008-06-11 | 萨文特医药公司 | 尿酸氧化酶的变体形式及其用途 |
CN102051348A (zh) * | 2009-10-27 | 2011-05-11 | 重庆富进生物医药有限公司 | 人源化重组尿酸酶及其突变体 |
-
2011
- 2011-06-30 CN CN 201110181447 patent/CN102260653B/zh active Active
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1322141A (zh) * | 1998-08-06 | 2001-11-14 | 山景药品公司 | 聚乙二醇或聚环氧乙烷-尿酸氧化酶结合物及其应用 |
US7056713B1 (en) * | 1998-08-06 | 2006-06-06 | Duke University | Urate oxidase |
WO2003011211A2 (en) * | 2001-08-02 | 2003-02-13 | Phoenix Pharmacologics, Inc. | Peg-modified uricase |
CN101198693A (zh) * | 2005-04-11 | 2008-06-11 | 萨文特医药公司 | 尿酸氧化酶的变体形式及其用途 |
CN102051348A (zh) * | 2009-10-27 | 2011-05-11 | 重庆富进生物医药有限公司 | 人源化重组尿酸酶及其突变体 |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2012109975A1 (zh) * | 2011-02-14 | 2012-08-23 | 重庆富进生物医药有限公司 | 聚乙二醇化犬源尿酸氧化酶类似物蛋白及其制备方法和用途 |
US9193967B2 (en) | 2011-02-14 | 2015-11-24 | Chun Zhang | Pegylated analogue protein or canine urate oxidase, preparation method and use thereof |
CN105412942A (zh) * | 2015-12-23 | 2016-03-23 | 沈阳三生制药有限责任公司 | 聚乙二醇化的重组产朊假丝酵母尿酸氧化酶冻干注射剂 |
CN108103079A (zh) * | 2017-06-20 | 2018-06-01 | 北京五加和分子医学研究所有限公司 | 一种高尿酸血症的基因治疗药物 |
CN108103079B (zh) * | 2017-06-20 | 2021-07-13 | 北京锦篮基因科技有限公司 | 一种高尿酸血症的基因治疗药物 |
CN113144174A (zh) * | 2020-01-22 | 2021-07-23 | 杭州远大生物制药有限公司 | 治疗高尿酸相关性疾病的药物 |
CN113144174B (zh) * | 2020-01-22 | 2023-07-04 | 杭州远大生物制药有限公司 | 治疗高尿酸相关性疾病的药物 |
CN111500550A (zh) * | 2020-04-02 | 2020-08-07 | 北京翼方生物科技有限责任公司 | 一种可降解人体血尿酸的过滤介质及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN102260653B (zh) | 2013-04-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5359030A (en) | Conjugation-stabilized polypeptide compositions, therapeutic delivery and diagnostic formulations comprising same, and method of making and using the same | |
CA2227891C (en) | Conjugation-stabilized therapeutic agent compositions, delivery and diagnostic formulations | |
CN101194016B (zh) | 尿酸氧化酶的变体形式及其用途 | |
CA2221690C (en) | Use of methioninase in anti-methionine and anti-homocysteine chemotherapy | |
CN102634492B (zh) | 聚乙二醇化犬源尿酸氧化酶类似物及其制备方法和应用 | |
CN102260653B (zh) | 一种peg化重组猪-人尿酸氧化酶融合蛋白的制备及应用方法 | |
CN101812438B (zh) | 一种精氨酸脱亚氨酶突变体及其制备与应用 | |
CN106554948B (zh) | 突变型尿酸酶、peg修饰的突变型尿酸酶及其应用 | |
CN102827270A (zh) | 一种聚乙二醇化艾塞那肽衍生物及其用途 | |
US10052368B2 (en) | Pegylated tissue kallikrein, and preparation method therefor and uses thereof | |
CN106834261A (zh) | 原核苯丙氨酸解氨酶变异体的组合物以及利用其组合物的方法 | |
JPH11512298A (ja) | ヒト成長ホルモン変異体 | |
JPH11199505A (ja) | 腫瘍壊死因子媒介疾患の治療または予防用薬剤学的組成物 | |
US20130052179A1 (en) | Arginine deiminase mutant and preparation and application thereof | |
CN102010473A (zh) | 重组胃泌酸调节素融合蛋白及其制备和应用 | |
WO2020228618A1 (zh) | 聚乙二醇修饰的尿酸氧化酶 | |
CN101302501B (zh) | 聚乙二醇化尿酸氧化酶化合物及其制备方法和其制剂及应用 | |
CN101928704A (zh) | 黄曲霉尿酸氧化酶的聚乙二醇修饰物及其制备方法 | |
CN102372770B (zh) | 一种抑血管生成素、纯化方法及含有它们的药物组合物 | |
KR20210094584A (ko) | Gdf15 유사체 및 체중을 감소시키고/시키거나 음식 섭취량을 감소시키는 데 사용하기 위한 방법 | |
WO2022095973A1 (zh) | 尿酸氧化酶制剂及其应用 | |
JP2023547675A (ja) | ポリエチレングリコール修飾尿酸オキシダーゼの製造方法 | |
CN103224557B (zh) | 一种长效型成纤维细胞生长因子-23拮抗剂的开发 | |
WO1998024473A1 (fr) | Inhibiteur de fibrose des tissus | |
CN101412995B (zh) | 聚乙二醇修饰的抑肽酶及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Owner name: RONG JUN Free format text: FORMER OWNER: BEIJING SHENGHONG BIOTECHNOLOGY CO., LTD. Effective date: 20130122 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 100031 XICHENG, BEIJING TO: 434007 JINGZHOU, HUBEI PROVINCE |
|
TA01 | Transfer of patent application right |
Effective date of registration: 20130122 Address after: Jingzhou City, Hubei province 434007 Shashi Wude Road No. 1 Singapore City International 3 35 Building 2 unit 101 room Applicant after: Rong Jun Address before: 100031, C, block 201, Heng Ao center, 26 Jin Mo Fang street, Beijing, Xicheng District Applicant before: Beijing Shenghong Biological Technology Co., Ltd. |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20151118 Address after: 430040 A7 Exhibition Center, 858, hi tech Avenue, East Lake Development Zone, Wuhan, Hubei, China Patentee after: Wuhan Haohai star biotechnology limited liability company Address before: Jingzhou City, Hubei province 434007 Shashi Wude Road No. 1 Singapore City International 3 35 Building 2 unit 101 room Patentee before: Rong Jun |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20210722 Address after: 434000 entrepreneurship service center of Huazhong nonggao District, Taihu Avenue, Jingzhou District, Jingzhou City, Hubei Province (No. 323) Patentee after: Jingzhou Changxin Biotechnology Co.,Ltd. Address before: A7 Exhibition Center, biomedical park, 858 Gaoxin Avenue, Donghu Development Zone, Wuhan City, Hubei Province, 430040 Patentee before: Wuhan Haohai star biotechnology LLC |